Expertise in
21
conditions

Yael Lebenthal

6 Weizmann Street, 6423906, 
Tel Aviv, TA, IL 
Expertise in
21
conditions
6 Weizmann Street, 6423906, 
Tel Aviv, TA, IL 

Overview

Yael Lebenthal practices practicing medicine in Tel Aviv, Israel.

Lebenthal is highly rated in 21 conditions, according to our data. Their clinical expertise encompasses Type 1 Diabetes (T1D), Congenital Hyperinsulinism, Precocious Puberty, Idiopathic Short Stature (ISS), and Adenoidectomy.

They are actively involved in clinical research, co-authoring 125 peer reviewed articles and participating in 7 clinical trials.

Locations

6 Weizmann Street, 6423906, Tel Aviv, TA 64239, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail
Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail
Enrollment Status: Completed
Publish Date: January 02, 2020
Intervention Type: Device
Study Phase: Not Applicable
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study
Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study
Enrollment Status: Terminated
Publish Date: December 21, 2018
Intervention Type: Other, Device
Study Phase: Not Applicable
The Influence of Growth Hormone (GH) Therapy on Short Stature Related Distress a Prospective Randomized Controlled Trial
The Influence of Growth Hormone (GH) Therapy on Short Stature Related Distress a Prospective Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: December 20, 2017
Intervention Type: Drug
Study Phase: Phase 4
Evaluation of Automated-Insulin Pump Setting Using the MD-Logic Pump Advisor -Minors Sub Study
Evaluation of Automated-Insulin Pump Setting Using the MD-Logic Pump Advisor -Minors Sub Study
Enrollment Status: Completed
Publish Date: January 11, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

125 Total Publications

International Consensus on the Diagnosis and Clinical Management of Idiopathic Short Stature: A Modified Delphi Method.
International Consensus on the Diagnosis and Clinical Management of Idiopathic Short Stature: A Modified Delphi Method.
Journal: Hormone research in paediatrics
Published: June 04, 2026

Frequently Asked Questions about Yael Lebenthal

Is Yael Lebenthal a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Yael Lebenthal is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yael Lebenthal participate in research or clinical trials?

Yes. Yael Lebenthal has published 125 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Yael Lebenthal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lebenthal's expertise for a condition
ConditionClose
    View All 16 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile